Share Price & Graph

Share Price Information(ASX: IVX)

Invion is leading the global research and development of the Photosoft™ technology for the treatment of a range of cancers. Invion holds the Australia and New Zealand license and distribution rights to the Photosoft™ technology. Research and clinical trials are funded by the technology licensor, The Cho Group, via an R&D services agreement with the Company. Invion is listed on ASX (ASX:IVX).<br><br>Invion is collaborating with leading research organisations, including Australia’s internationally recognised Hudson Institute of Medical Research, to advance the Photosoft™ technology for development as a potential treatment for a range of cancers.